CDH17 and neoplasm: Additionally, to extend our findings, we explored whether IR700@Nb289‐OMVs plus NIR could effectively regress tumour progression in another CDH17‐positive tumour model induced by the pancreatic cancer cell line Panc02 (Figure 3Q).